New York State Common Retirement Fund’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-74,700
| Closed | -$284K | – | 3357 |
|
|
2020
Q1 | $284K | Hold |
74,700
| – | – | ﹤0.01% | 2295 |
|
|
2019
Q4 | $380K | Sell |
74,700
-69,548
| -48% | -$368K | ﹤0.01% | 2434 |
|
|
2019
Q3 | $729K | Sell |
144,248
-643
| -0.4% | -$3.21K | ﹤0.01% | 2140 |
|
|
2019
Q2 | $894K | Sell |
144,891
-330
| -0.2% | -$1.59K | ﹤0.01% | 2074 |
|
|
2019
Q1 | $674K | Sell |
145,221
-34,517
| -19% | -$156K | ﹤0.01% | 2170 |
|
|
2018
Q4 | $755K | Buy |
179,738
+3,500
| +2% | +$17.8K | ﹤0.01% | 2068 |
|
|
2018
Q3 | $1.1M | Hold |
176,238
| – | – | ﹤0.01% | 2031 |
|
|
2018
Q2 | $1.42M | Sell |
176,238
-422
| -0.2% | -$3.22K | ﹤0.01% | 1897 |
|
|
2018
Q1 | $1.32M | Buy |
176,660
+24,979
| +16% | +$166K | ﹤0.01% | 1861 |
|
|
2017
Q4 | $903K | Sell |
151,681
-15,247
| -9% | -$92.6K | ﹤0.01% | 2093 |
|
|
2017
Q3 | $1.23M | Sell |
166,928
-72,597
| -30% | -$461K | ﹤0.01% | 1902 |
|
|
2017
Q2 | $1.63M | Buy |
239,525
+23,723
| +11% | +$175K | ﹤0.01% | 1808 |
|
|
2017
Q1 | $2.04M | Buy |
215,802
+6,772
| +3% | +$67.6K | ﹤0.01% | 1663 |
|
|
2016
Q4 | $1.81M | Hold |
209,030
| – | – | ﹤0.01% | 1752 |
|
|
2016
Q3 | $1.32M | Buy |
209,030
+57,490
| +38% | +$348K | ﹤0.01% | 1870 |
|
|
2016
Q2 | $639K | Hold |
151,540
| – | – | ﹤0.01% | 2175 |
|
|
2016
Q1 | $661K | Sell |
151,540
-264
| -0.2% | -$1.18K | ﹤0.01% | 2140 |
|
|
2015
Q4 | $931K | Buy |
151,804
+5,382
| +4% | +$35.3K | ﹤0.01% | 2021 |
|
|
2015
Q3 | $838K | Buy |
146,422
+30,634
| +26% | +$235K | ﹤0.01% | 2049 |
|
|
2015
Q2 | $864K | Buy |
115,788
+20,842
| +22% | +$126K | ﹤0.01% | 2261 |
|
|
2015
Q1 | $568K | Buy |
+94,946
| New | +$598K | ﹤0.01% | 2005 |
|
Other funds holding PGNX
New York State Common Retirement Fund's PGNX Position: Q2 2020 in Review
New York State Common Retirement Fund sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 74,700 shares — an estimated $284K sold.
New York State Common Retirement Fund first reported a position in PGNX in Q1 2015 and held it in 21 quarters. The position peaked at $2.04M in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.
- New York State Common Retirement Fund reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
- New York State Common Retirement Fund sold 74,700 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $284K.
- New York State Common Retirement Fund first reported a position in Progenics Pharmaceuticals Inc in Q1 2015 and held it in 21 quarters.
- New York State Common Retirement Fund's Progenics Pharmaceuticals Inc position peaked at $2.04M in Q1 2017.
- 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.
Based on New York State Common Retirement Fund's 13F filing for Q2 2020, filed 7 Aug 2020.